IP Infusion to Demonstrate How Network Operators Can Build Open, Smarter, Simpler Networks at China SDN/NFV/AI Conference

BEIJING, CHINA, April 15, 2019 – IP Infusion, a leading provider of intelligent network software for telecom and data communications services, will be featuring disaggregated networking solutions using OcNOS™, the industry’s first full-featured commercial network operating system for network operators, carriers and enterprises, at the China SDN/NFV/AI Conference to be held on April 17-18 at the Crowne Plaza Beijing Sun Palace Hotel in Beijing, China.

“IP Infusion brings the benefits of disaggregation to help service providers build open, smarter and simpler networks to help reduce their total cost of ownership by 60 percent and to deliver 99.999 percent network uptime,” said Atsushi Ogata, President and CEO of IP Infusion. “Whether it’s for 5G networks, cloud gateway/provider edge, data centers, DCI/Metro Optical Networks, Internet Exchange Points, Passive Optical Networks or Cell Site Routers, IP Infusion’s OcNOS offers unparalleled disaggregated networks solutions.”

OcNOS solutions include DC Clos, DCI (Data Center Interconnectivity), Optical Packet Transponder, IXP Peering, Cloud Gateway, Provider Edge, Passive Optical Networks (PON), Metro Networks and Mobile Backhaul Gateway/CSR. OcNOS is the industry’s first full-featured network OS for White Box and features hybrid, centralized or distribute network support; scalable, modular high-performance network; and a robust data plane built on merchant silicon.

About IP Infusion

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators with over 500 customers and thousands of deployments. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness.

IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.

-end-

Media Contact

Katherine Verducci, 1903 PR, kverducci@1903pr.com, 408.429.5779